Subject Satisfaction with Trifarotene 50 μg/g Cream in the Treatment of Facial and Truncal Acne Vulgaris: A Case Series
Abstract There is a paucity of literature covering patient-reported outcomes of treatments for truncal acne. Trifarotene 50 μg/g cream is a novel retinoid molecule approved for once-daily topical treatment of facial and truncal acne vulgaris. As physicians are starting to gain real-world experience...
Main Authors: | Sandra M. Johnson, Rajeev Chavda, Janet C. DuBois |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-07-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s13555-020-00417-4 |
Similar Items
-
Trifarotene: A Current Review and Perspectives in Dermatology
by: Terenzio Cosio, et al.
Published: (2021-02-01) -
Transcriptomics Analysis Indicates Trifarotene Reverses Acne-Related Gene Expression Changes
by: Brigitte Dreno, et al.
Published: (2021-10-01) -
Truncal Acne: An Overview
by: Yu Ri Woo, et al.
Published: (2022-06-01) -
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study
by: Stephen Schleicher, et al.
Published: (2023-10-01) -
Truncal Acne in Adolescents and Young Adults: Self-reported Perception
by: Fabienne Ballanger, et al.
Published: (2023-03-01)